Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Pacini

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Thyroid : Official Journal of the American Thyroid Association|October 29, 2009
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer, David S Cooper, Gerard M Doherty, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
Expanding indications for recombinant human TSH in thyroid cancerBryan R Haugen, David S Cooper, Charles H Emerson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawalHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Lancet (London, England)|April 29, 2014
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialMarcia S Brose, Christopher M Nutting, Barbara Jarzab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2015
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid CancerMartin Schlumberger, Barbara Jarzab, Maria E Cabanillas, et al.
Thyroid : Official Journal of the American Thyroid Association|March 27, 2015
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinomaSamuel A Wells, Sylvia L Asa, Henning Dralle, et al.
Thyroid : Official Journal of the American Thyroid Association|October 15, 2015
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerBryan R Haugen, Erik K Alexander, Keith C Bible, et al.
Thyroid : Official Journal of the American Thyroid Association|January 25, 2017
American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear FeaturesBryan R Haugen, Anna M Sawka, Erik K Alexander, et al.
Cancer|April 28, 2015
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentMaria E Cabanillas, Martin Schlumberger, Barbara Jarzab, et al.
The Journal of Clinical Endocrinology and Metabolism|January 6, 2006
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawalPamela R Schroeder, Bryan R Haugen, Furio Pacini, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Thyroid : Official Journal of the American Thyroid Association|October 29, 2009
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer, David S Cooper, Gerard M Doherty, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
Expanding indications for recombinant human TSH in thyroid cancerBryan R Haugen, David S Cooper, Charles H Emerson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawalHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Lancet (London, England)|April 29, 2014
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialMarcia S Brose, Christopher M Nutting, Barbara Jarzab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2015
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid CancerMartin Schlumberger, Barbara Jarzab, Maria E Cabanillas, et al.
Thyroid : Official Journal of the American Thyroid Association|March 27, 2015
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinomaSamuel A Wells, Sylvia L Asa, Henning Dralle, et al.
Thyroid : Official Journal of the American Thyroid Association|October 15, 2015
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerBryan R Haugen, Erik K Alexander, Keith C Bible, et al.
Thyroid : Official Journal of the American Thyroid Association|January 25, 2017
American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear FeaturesBryan R Haugen, Anna M Sawka, Erik K Alexander, et al.
Cancer|April 28, 2015
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentMaria E Cabanillas, Martin Schlumberger, Barbara Jarzab, et al.
The Journal of Clinical Endocrinology and Metabolism|January 6, 2006
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawalPamela R Schroeder, Bryan R Haugen, Furio Pacini, et al.
Pageof 15